Fintel on MSN17d
Wells Fargo Upgrades C4 Therapeutics (CCCC)Fintel reports that on December 19, 2024, Wells Fargo upgraded their outlook for C4 Therapeutics (NasdaqGS:CCCC) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback